Standout Papers

Prevalence of Steatotic Liver Disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017–2020 2023 2026 202486
  1. Prevalence of Steatotic Liver Disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017–2020 (2023)
    Markos Kalligeros, Athanasios Vassilopoulos et al. Clinical Gastroenterology and Hepatology

Immediate Impact

1 by Nobel laureates 1 from Science/Nature 45 standout
Sub-graph 1 of 21

Citing Papers

Catalytic Asymmetric Construction of Chiral Polysubstituted 3-Azabicyclo[3.1.1]heptanes by Copper-Catalyzed Stereoselective Formal [4π+2σ] Cycloaddition
2024 Standout
Epidemiology of metabolic dysfunction-associated steatotic liver disease
2024 Standout
7 intermediate papers

Works of Athanasios Vassilopoulos being referenced

Prevalence of Steatotic Liver Disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017–2020
2023 Standout
Synthesis of chroman analogues of lipoic acid and evaluation of their activity against reperfusion arrhythmias
2004
and 1 more

Author Peers

Author Last Decade Papers Cites
Athanasios Vassilopoulos 114 45 14 91 59 14 285
Jeffrey Nadelson 79 29 14 81 64 16 308
Adriana Fontes 155 24 14 49 93 11 292
Tamiko Ohkura 114 33 21 32 86 23 214
Cristiana Porcu 138 40 8 16 75 14 326
Mathias Liljeblad 128 41 20 15 112 11 273
Fatma El Zahraa Ammar Mohamed 128 148 6 24 74 23 323
Chia Hsin Ju 61 25 2 21 100 7 325
Jeong-Hyun Yoon 41 21 5 23 90 20 330
Hong Shen 63 41 7 9 78 8 259
Qingxian Huang 67 17 32 10 93 15 326

All Works

Loading papers...

Rankless by CCL
2026